Pixium Vision announces successful activations with PRIMA, its breakthrough Bionic Vision System, in the first three patients with Atrophic Dry-AMDadmin2019-09-11T17:31:58+02:00March 13th, 2018|
Pixium Vision announces its 2017 annual results and provides business updateadmin2019-09-11T17:31:58+02:00February 8th, 2018|
Pixium Vision completes World’s First Successful Activation in Human of PRIMA Bionic Vision Systemadmin2019-09-11T17:32:00+02:00January 25th, 2018|
Pixium Vision receives FDA approval to begin human clinical study of its PRIMA retinal implant in the USadmin2019-09-11T17:32:00+02:00January 4th, 2018|
Pixium Vision to present bionic vision systems update at Jefferies Healthcare Conferenceadmin2019-09-11T17:32:17+02:00November 8th, 2017|
Pixium Vision Reports Third Quarter Cash Positions and Updates on Development of its Businessadmin2019-09-11T17:32:18+02:00October 26th, 2017|
Pixium Vision Establishes an Equity Line Financing with Kepler Cheuvreuxadmin2019-09-11T17:32:18+02:00October 23rd, 2017|
Pixium Vision receives approval for First-in-Human Clinical Trial of PRIMA, its miniaturized sub-retinal implantadmin2019-09-11T17:32:18+02:00October 19th, 2017|
Pixium Vision announces updates on its Epi-retinal IRIS®II Bionic Vision Systemadmin2019-09-11T17:32:20+02:00September 27th, 2017|
Pixium Vision reports on June 30 2017 financial statements and updates on development of its businessadmin2019-09-11T17:32:22+02:00July 27th, 2017|
